Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
filingDate |
2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da35f4b4303aae4dfc15407b0ce96c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbf97abfda406904c3191ab1e0395b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b940946ee7a3f3384402f2492c7d55d |
publicationDate |
2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-602478-A |
titleOfInvention |
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
abstract |
This disclosure provides a method of treating a subject afflicted with rheumatoid arthritis comprising periodically administering to the subject an amount of laquimmod or pharmaceutically acceptable salt thereof and an amount of methotrexate wherein the amounts when taken together are effective to treat the subject. This disclosure also provides laqumimod or pharmaceutically acceptable salt thereof for use in combination with methotrexate in treating a subject afflicted with rheumatoid arthritis. This disclosure also provides a pharmaceutical composition comprising an amount of laquimmod or pharmaceutically acceptable salt thereof and an amount of methotrexate for use in treating a subject afflicted with rheumatoid arthritis. |
priorityDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |